GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Archived. This submission is more than a year old. Votes and new comments are closed, and some of the advice in it may have been superseded — check the community wiki for the current version.
6k
c/retatrutide·posted 1 year ago by u/trialwatch_theo

dose escalation: the version I wish someone had shown me in week 1

Discussion Long Haul ×7 Slow Clap ×3 Cold Box ×3

Confession thread, sort of.

I went from 5mg to 1.7mg much faster than I should have because the scale had stalled and I got impatient. The stall broke about 10 weeks later, at which point I had no way of knowing whether the dose increase did anything or whether it would have broken anyway.

So now I have injection-site soreness I did not need and a data point I cannot interpret. Two lessons in one.

Posting it in the hope that somebody at week 22 reads it before doing the same thing.

6,738 up / 697 down91% upvoted56 commentsid 1v5x482 Dec 2024

56 comments

18 in this archive, depth 5

best — the order this archive was captured in

u/freya_baptista556 points·1 year ago

Strongly agree. Heart rate escalation needs the actual data, not impressions.

replysharereportpermalink
u/cagrilintide_enthusiast186 points·1 year ago

Strongly agree.

Disagree on that part. 98.1% and 99.2% on the same vial is normal.

replysharereportpermalink
u/emil_agyeman64 points·1 year ago

retatrutide is not approved anywhere for human use, posts must not read as instructions

replysharereportpermalink
u/trialwatch_theoOPtrial nerd416 points·1 year ago

The heart rate signal in TRIUMPH is real and concerning. Higher doses had higher mean HR changes.

replysharereportpermalink
u/nikhil_asante133 points·1 year ago

The heart rate signal in TRIUMPH is real and concerning.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

replysharereportpermalink
u/iman_castellanos394 points·1 year ago·edited

The evidence standard in c/vendorvetting gets called too strict about once a month, and every time, the thread ends with the complainant agreeing.

replysharereportpermalink
u/tired_ledger_notes101 points·1 year ago·edited

This is correct. Triple agonism is genuinely different.

replysharereportpermalink
u/nikhil_asante84 points·1 year ago

Are you quoting phase 2 or is there phase 3 data now?

replysharereportpermalink
u/yannick_barros80 points·1 year ago

triple agonism is phase 2, do not generalise

replysharereportpermalink
u/trialwatch_theoOPtrial nerd60 points·1 year ago

The glucagon component does different things than dual agonism. The injection-site soreness are not just amplified versions.

replysharereportpermalink
u/cold_chromatogram_only37 points·1 year ago

TRIUMPH data is phase 2, not phase 3, smaller n and shorter

replysharereportpermalink
u/jarno_cabrera317 points·1 year ago

No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.

replysharereportpermalink
u/incretin_ivypharmacology266 points·1 year ago

the 7.5mg arm is different from 0.25mg, results do not transfer

replysharereportpermalink
u/emil_wojcik76 points·1 year ago

TRIUMPH data is phase 2, not phase 3, smaller n and shorter

replysharereportpermalink
u/yusuf_ramos24 points·1 year ago·edited

Strongly agree. Heart rate escalation needs the actual data, not impressions.

replysharereportpermalink
u/careful_gradient_notes48 points·1 year ago

Respectfully this is a sample of one presented as a finding.

replysharereportpermalink
u/rekha_vestergaard26 points·1 year ago

triple agonism is phase 2, do not generalise

replysharereportpermalink
u/kavya_kravchenko-32 points·1 year ago

No.

Disagree on that part. 96.8% and 96.2% on the same vial is normal.

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/retatrutide

Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.

65kmembers
130submissions
Sep 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/retatrutide rules
  1. Retatrutide is not approved anywhere for human use. Posts must not read as usage instructions.
  2. Phase 2 numbers are not maintenance numbers. Cite the trial and the dose arm.
  3. Heart-rate and dose-escalation reports need actual measurements, not impressions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.